A modified peptide shows promise for fighting tumors
Past research has shown how native C-type natriuretic peptide (CNP), a 22-amino acid peptide produced by endothelial cells ...
manilatimes21 天
COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes
"In preclinical studies to date, CNP-103 has demonstrated the ability to stop T1D disease progression while creating an enhanced pro-regulatory environment with reduced inflammatory ... who have Stage ...
Morningstar20 天
COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes
“In preclinical studies to date, CNP-103 has demonstrated the ability to stop T1D disease progression while creating an enhanced pro-regulatory ... T1D as well as C-peptide >0.2 ng/mL.